21.07.2016 Views

Vitamin D and Health

SACN_Vitamin_D_and_Health_report

SACN_Vitamin_D_and_Health_report

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

thresholds, although there has also been disagreement over the appropriate threshold concentration<br />

for a specific functional endpoint(s).<br />

4.29 In the UK, for example, a serum 25(OH)D concentration of 25 nmol/L is currently used as a threshold<br />

(cut-off) for defining the lower limit of adequacy (DH, 1998), based on evidence suggesting risk of<br />

rickets <strong>and</strong> osteomalacia is increased at concentrations below this level.<br />

4.30 The IOM, using bone health as the basis for developing Dietary Reference Intakes (DRIs) for vitamin D,<br />

proposed a serum 25(OH)D concentration of 40 nmol/L as the value above which approximately half<br />

the population might meet its vitamin D requirement (in terms of bone health <strong>and</strong> below which half<br />

might not) <strong>and</strong> 50 nmol/L as the concentration that would meet the requirement of nearly all (i.e.,<br />

97.5%) ‘normal healthy persons’. The IOM DRI committee also concluded that: individuals are at risk<br />

of deficiency at serum 25(OH)D concentrations < 30 nmol/L; some, but not all, individuals are<br />

potentially at risk for inadequacy at serum 25(OH)D concentrations from 30 up to 50 nmol/L; <strong>and</strong><br />

practically all individuals are sufficient at concentrations of 50 nmol/L <strong>and</strong> above.<br />

4.31 In contrast, the Endocrine Society Task Force on <strong>Vitamin</strong> D (Holick et al., 2011) concluded that<br />

‘individuals should be identified as vitamin-D-deficient at a cut-off level of 50 nmol/L serum 25(OH)D’<br />

<strong>and</strong> ‘to maximise the effect of vitamin D on calcium, bone, <strong>and</strong> muscle metabolism’, serum 25(OH)D<br />

concentration ‘should exceed 75 nmol/L’.<br />

4.32 While both the IOM DRI committee <strong>and</strong> the Endocrine Society Task Force appeared to agree that<br />

there was insufficient evidence of a causative link between 25(OH)D concentration <strong>and</strong> any nonskeletal<br />

disease outcomes, others have proposed serum 25(OH)D thresholds between 50-120 nmol/L<br />

to reduce the risk of adverse non-skeletal outcomes (Zittermann, 2003; Holick, 2004b).<br />

4.33 The wide variation in measurements of serum 25(OH)D concentration, made using different methods<br />

<strong>and</strong> in different laboratories, should be taken into account in the interpretation of studies that have<br />

examined the relationship between serum 25(OH)D concentration <strong>and</strong> health outcomes.<br />

33

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!